Paraneoplastic Neurological Syndrome
8
1
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
9 treatments under study, led by Test Of Biological Samples
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (8)
Metabolic Imaging for Diagnosis and Prognostication of Autoimmune encephalitiS
Diagnostic Performance of a Commercial Assay for the Detection of Neuronal Antibodies
Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes
New Biomarkers in Auto-immune Encephalitis and Neurological Paraneoplastic Syndromes
Epidemiology of Autoimmune Encephalitides and Paraneoplastic Neurological Syndromes in Sweden
HLA Analysis in Autoimmune Encephalitis and Related Disorders: Part II
Methylated DNA Detect in Paraneoplastic Syndrome of Nervous System
Incidence of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis
Research Network
Common Treatments
- Test Of Biological Samples1
- Petscan Analysis1
- Positive Methylated Dna1
- Autoimmune Encephalitis And Paraneoplastic Neurological Syndromes1
- Genetic And Immunology Tests1
Active Sponsors
- Hospices Civils de Lyon6
- Uppsala University1
- Peking University Third Hospital1
Top Investigators
Uppsala University
Peking University Third Hospital
Uppsala University
Hospices Civils de Lyon
center for paraneoplastic neurological syndromes and autoimmune encephalitis
Related Conditions
- Autoimmune Encephalitis7